Positron emission computed tomography targeting urokinase plasminogen activator receptor (uPAR) in cancer: a systematic review.
Riccardo CameddaViviana FrantellizziRoberta DanieliGiuseppe De VincentisLuca FilippiPublished in: Expert review of anticancer therapy (2024)
uPAR-PET appears to be a promising imaging tool in well-selected oncological settings, but it needs to be validated by multicentre collaboration.
Keyphrases
- computed tomography
- positron emission tomography
- papillary thyroid
- high resolution
- magnetic resonance imaging
- squamous cell
- clinical trial
- pet ct
- rectal cancer
- study protocol
- cancer therapy
- dual energy
- contrast enhanced
- image quality
- double blind
- squamous cell carcinoma
- prostate cancer
- pet imaging
- cross sectional
- lymph node metastasis
- childhood cancer
- young adults
- mass spectrometry